Maulik Nanavaty - Net Worth and Insider Trading

Maulik Nanavaty Net Worth

The estimated net worth of Maulik Nanavaty is at least $16 Million dollars as of 2024-03-28. Maulik Nanavaty is the SVP & Pres, Neuromodulation of Boston Scientific Corp and owns about 228,993 shares of Boston Scientific Corp (BSX) stock worth over $16 Million. Maulik Nanavaty is also the Director of Rani Therapeutics Holdings Inc and owns about 11,517 shares of Rani Therapeutics Holdings Inc (RANI) stock worth over $35,818. Details can be seen in Maulik Nanavaty's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Maulik Nanavaty has not made any transactions after 2023-11-16 and currently still holds the listed stock(s).

Transaction Summary of Maulik Nanavaty

To

Maulik Nanavaty Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Maulik Nanavaty owns 2 companies in total, including Boston Scientific Corp () , and Rani Therapeutics Holdings Inc () .

Click here to see the complete history of Maulik Nanavaty’s form 4 insider trades.

Insider Ownership Summary of Maulik Nanavaty

Ticker Comapny Transaction Date Type of Owner
Boston Scientific Corp 2020-08-28 SVP & President & Neuromodula
Rani Therapeutics Holdings Inc 2023-11-16 director

Maulik Nanavaty Latest Holdings Summary

Maulik Nanavaty currently owns a total of 2 stocks. Among these stocks, Maulik Nanavaty owns 228,993 shares of Boston Scientific Corp (BSX) as of August 28, 2020, with a value of $16 Million and a weighting of 99.77%. Maulik Nanavaty also owns 11,517 shares of Rani Therapeutics Holdings Inc (RANI) as of November 16, 2023, with a value of $35,818 and a weighting of 0.23%.

Latest Holdings of Maulik Nanavaty

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BSX Boston Scientific Corp 2020-08-28 228,993 68.49 15,683,731
RANI Rani Therapeutics Holdings Inc 2023-11-16 11,517 3.11 35,818

Holding Weightings of Maulik Nanavaty


Maulik Nanavaty Form 4 Trading Tracker

According to the SEC Form 4 filings, Maulik Nanavaty has made a total of 13 transactions in Boston Scientific Corp (BSX) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Boston Scientific Corp is the sale of 38,000 shares on August 28, 2020, which brought Maulik Nanavaty around $2 Million.

According to the SEC Form 4 filings, Maulik Nanavaty has made a total of 1 transactions in Rani Therapeutics Holdings Inc (RANI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Rani Therapeutics Holdings Inc is the acquisition of 500 shares on November 16, 2023, which cost Maulik Nanavaty around $990.

Insider Trading History of Maulik Nanavaty

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Maulik Nanavaty Trading Performance

GuruFocus tracks the stock performance after each of Maulik Nanavaty's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Maulik Nanavaty is 73.23%. GuruFocus also compares Maulik Nanavaty's trading performance to market benchmark return within the same time period. The performance of stocks bought by Maulik Nanavaty within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Maulik Nanavaty's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Maulik Nanavaty

Average Relative Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 43.43 73.23
Relative Return to S&P 500(%) 38.75 62.2

Maulik Nanavaty Ownership Network

Ownership Network List of Maulik Nanavaty

No Data

Ownership Network Relation of Maulik Nanavaty


Maulik Nanavaty Owned Company Details

What does Boston Scientific Corp do?

Who are the key executives at Boston Scientific Corp?

Maulik Nanavaty is the SVP & President & Neuromodula of Boston Scientific Corp. Other key executives at Boston Scientific Corp include SVP&Pres & Periph Intervent Jeffrey B. Mirviss , SVP & Human Resources Wendy Carruthers , and EVP and CFO Daniel J. Brennan .

Boston Scientific Corp () Insider Trades Summary

Over the past 18 months, Maulik Nanavaty made no insider transaction in Boston Scientific Corp (). Other recent insider transactions involving Boston Scientific Corp () include a net sale of 153,177 shares made by Wendy Carruthers , a net sale of 151,591 shares made by Jeffrey B. Mirviss , and a net sale of 252,070 shares made by Joseph Michael Fitzgerald .

In summary, during the past 3 months, insiders sold 189,797 shares of Boston Scientific Corp () in total and bought 0 shares, with a net sale of 189,797 shares. During the past 18 months, 1,375,231 shares of Boston Scientific Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,375,231 shares.

Boston Scientific Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Boston Scientific Corp Insider Transactions

No Available Data

Maulik Nanavaty Mailing Address

Above is the net worth, insider trading, and ownership report for Maulik Nanavaty. You might contact Maulik Nanavaty via mailing address: Boston Scientific Corporation, 300 Boston Scientific Way, Marlborough Ma 01752-1234.

Discussions on Maulik Nanavaty

No discussions yet.